Merck begins overseas recall of HDL cholesterol drug
Merck in December said Tredaptive did no better in the study at preventing heart attacks, deaths or
strokes than traditional statin drugs that lower LDL cholesterol. (See Reuters story of December 20,
2012.)
Source: Modern Medicine - Category: Journals (General) Source Type: news
More News: Cardiology | Cholesterol | General Medicine | Heart | Merck | Statin Therapy | Stroke | Study